STUART J. BRINK, Boston (USA)
Senior Pediatric Endocrinologist at NEDEC (New England Diabetes and Endocrinology Center), Waltham, Massachusetts, USA
Associate Clinical Professor of Pediatrics at Tufts University School of Medicine, Boston MA, USA. Clinical Instructor in Pediatrics at Harvard Medical School.
Past-President of ISPAD (the International Society for Pediatric and Adolescent Diabetes) and has been ISPAD's Secretary-General. Current ISPAD International Education Committee Chair.
ISPAD representative on the Steering Committee of GPED (Global Pediatric Endocrine and Diabetes consortium). Member in National Board of Directors of the American Diabetes Association.
Professional member of the American Association of Clinical Endocrinologist (AACE), the Lawson Wilkins Pediatric Endocrine Society (LWPES) and the Endocrine Society.
He was a co-investigator of the NIH-sponsored DCCT for ten years and also served on the American Academy of Pediatrics Endocrine executive and on the International Diabetes Federation`s Youth Section.
Stuart Brink is Doctor Honoris Causa of the University of Medicine and Pharmacy "Victor Babes" Timisoara.
2016 - Honorary Citizen of Timisoara.
Mehul Dattani, Londra (UK)
Professor Mehul Dattani is Head of Paediatric Endocrinology at Great Ormond Street Hospital for Children (GOSH), University College London Hospitals (UCLH) and Institute of Child Health (ICH).
His main research interest lies in the area of disorders of hypothalamo-pituitary disorders such as congenital hypopituitarism including disorders such as Septo-Optic Dysplasia, tumours (craniopharyngioma), disorders of gonadotrophin secretion such as hypogonadotrophic hypoogonadism, and hypothalamic obesity.
He has identified mutations in a number of known and novel genes implicated in disorders of hypothalamo-pituitary development and hypothalamo-pituitary tumours, and his work has been recognised nationally and internationally. Other research interests include identification of the molecular basis of rare endocrine disorders affecting the thyroid, adrenals and gonads.
Has received national and international awards, including the Donald Paterson prize awarded by the Royal College of Paediatrics and Child Health and the Henning Andersen prize awarded by the ESPE.
He is member of the MRC College of Experts, on the Editorial Board of the Journal of Clinical Endocrinology and Metabolism. He has recently been appointed to the Advisory Board of a new journal launched by the Company of Biologists, Disease Models and Mechanisms.
He is Chair of the British Society for Paediatric Endocrinology and Diabetes (BSPED), and Chair-Elect of the Programme Organizing Committee of the ESPE.
John W Gregory, Cardiff (UK)
Professor in Paediatric Endocrinology School of Medicine, Cardiff University.
Is graduated from Dundee University and trained in paediatric diabetes in Sheffield, Dundee and Newcastle upon Tyne. Until 2019, he provided a diabetes service for approximately 235 children with diabetes living in Cardiff and continues to lead a research programme investigating delivery of clinical care to children with diabetes.
He has contributed to a randomised controlled trial of multiple daily injections with pumps (The SCIPI Study) and is the paediatric lead for the Ustekid Study, an RCT evaluating Ustekinemab in newly diagnosed children with diabetes. He leading a programme of work using anonymised data linkage of The Brecon Cohort of children with newly diagnosed diabetes in Wales (1995-present) to evaluate long-term outcomes of childhood onset diabetes.
On behalf of the European Society for Paediatric Endocrinology (ESPE) in the past has led the Paediatric Endocrine Training Centres for Africa in Nairobi and Lagos. He now leads the annual ESPE Winter School targeting trainees in Eastern Europe. In recognition for these contributions, he was awarded ESPE’s Outstanding Clinician Award for 2018. He is Principal Regional Examiner for the Middle-East for the MRCPCH exam for The Royal College of Paediatrics and Child Health. He has published over 100 papers in peer-reviewed journals and is co-author of Practical Endocrinology and Diabetes in Children, now being published in its fourth edition.
ZE'EV HOCHBERG, Haifa (ISRAEL)
Ze'ev Hochberg is an Emeritus Professor of Pediatrics and Endocrinology at the Rappaport Faculty of Medicine, Technion, Haifa, Israel.
He received his MD from Tel Aviv University and PhD from the Technion. He is certified as an endocrinologist, a pediatrician and a pediatric endocrinologist.
In the 1980s he described in a series of articles the mechanism of hereditary vitamin D resistant rickets due to vitamin D receptor defect.
He is has made important discoveries about the growth hormone (GH) receptor, and the mechanisms of GH and thyroid hormones on bone growth.
In the 2000s he described the delayed infancy-childhood transition as the mechanism explaining 50% of children with idiopathic short stature. He defined the life history stage of juvenility and the impacts of short or long infancy and juvenility on growth and puberty.
He is the Editor-in Chief of the Yearbook in Pediatric Endocrinology, an editor of additional 8 books, the author of over 300 peer-reviewed scientific articles and three monographs.
He is the past President of the European Society for Paediatric Endocrinology (ESPE) and the founder and past Secretary General of Global Pediatric Endocrinology and Diabetes GPED supporting pediatric endocrinology in developing countries. He is the winner of the prestigious Andrea Prader Prize for world leadership in Pediatric Endocrinology and the ESPE Research Award.
Moshe Phillip, Tel-Aviv (Israel)
Prof. Moshe Phillip graduated from Ben Gurion University, Beer Sheba, Israel, in 1983 and specialized in pediatric endocrinology in 1989-1992 at the University of Maryland School of Medicine, in Baltimore.
He is the Director of the Institute for Endocrinology and Diabetes, the National Center for Childhood Diabetes at Schneider Children's Medical Center, Petah Tikva, Israel since 1997, and serves as Vice Dean for R&D as well as a Chair of the Irene and Nicholas Marsh Fund for Endocrinology and Diabetes at the Sackler Faculty of Medicine, Tel Aviv University.
Prof. Phillip is active in both clinical and basic research focusing on childhood diabetes, growth, nutrition, and obesity. In recent years he is focusing on: diabetes technologies and the interaction between nutrition and growth.
Prof. Phillip is a member of national and international organizations, such as the, the Israeli National Committee for Diabetes, International Society for Pediatric and Adolescent Diabetes (ISPAD), European Society for Paediatric Endocrinology (ESPE) Pediatric Endocrine Society (PES), Endocrine Society and more. He is co-founder and Co-Chairman of the International Conference for Advanced Technologies and Treatments for Diabetes (ATTD) and of the International Conference on Nutrition and Growth (N&G).
Prof. Phillip established DreaMed-Diabetes Ltd. for moving into the phase of commercialization of the Artificial Pancreas first developed at Schneider Hospital.
Two other companies were established: Nutriteen Ltd. and NG Solutions Ltd. for the commercialization of a special formula - a protein powder, blended into a shake, that boosts children’s nutrition and helps them grow. Prof. Phillip has more than 270 publications, the ATTD Yearbook, N&G yearbook, as well as chapters in other books.
Martin Wabitsch, Ulm (Germany)
Martin Wabitsch is Professor of Pediatrics at the University of Ulm, Germany and is Head of the Division of Pediatric Endocrinology and Diabetes at the Department of Pediatrics and Adolescents Medicine at the Ulm University Medical Center.
He studied Medicine in Berlin (Free University) and Ulm, graduated in 1989 and got his PhD in 1990 (Chairman: Ernst Friedrich Pfeiffer). He did his early clinical training in Ulm and at the Johns Hopkins Hospital in Baltimore, USA. His training in experimental research he did in the labs of Hans Hauner (Ulm), Gerard Ailhaud (Nice, France) and Pierre de Meyts (Gentofte, Denmark). At the Hagedorn Research Institute he performed studies on the growth hormone receptor in human adipocytes supported by an ESPE research fellowship. He has won several research prices of scientific societies (e.g. ESPE, EASO). He has been President of the German Society for Paediatric Endocrinology and Diabetes and the German Society for the Study of Obesity.
His clinical research focus comprises childhood obesity, the physiology of body weight regulation in children, leptin deficiency in humans, and rare lipodystrophy syndromes. His experimental research focus is the biology of the human adipocyte for which he has established in vitro models for studying white and brown adipocytes.
HARTMUT WOLLMANN, Berlin (Germany)
Since 1992, Dr. Hartmut Wollmann is Scientific assistant, Growth Research Center, Tübingen, (Prof. Dr. MB Ranke), with multiple research projects (pediatrics, endocrinology, neonatology: growth and growth disorders; growth factors; growth hormone treatment; GHD in adults; growth in syndromes (Russell-Silver syndrome; Prader-Willi syndrome); intrauterine growth retardation; long-term consequences of IUGR; perinatal endocrinology: perinatal growth regulation, thyroid function in premature infants; Congenital adrenal hyperplasia; Genetic causes of disease (esp. Silver-Russell syndrome).
Since 2001 Dr. Hartmut Wollmann is Medical Director Endocrine Care/Global Medical Affairs Pediatric Endocrinology – Europe (including eastern Europe and middle east) Pharmacia Ltd and Pfizer Inc.
Since 2007 Professor Hartmut Wollmann is Medical Director EBT, with responsibility for Pediatric Endocrinology Europe.
Prof. dr. Iulian VeleaPreşedinte ENDOPED
+40 748 33 13 67
Ș.L. dr. Corina PaulPreședinte CONGRES
+40 748 33 13 68